Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Alment praktiserende læge Camilla Lund Borch ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   6.0% 7.2% 6.5% 3.3% 10.2% 8.6% 10.1% 9.9%   Credit score (0-100)   40 35 36 53 23 28 24 25   Credit rating   BBB BBB BBB BBB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,498 1,562 1,670 1,473 1,745 1,328 0.0 0.0   EBITDA   810 887 1,036 760 1,026 617 0.0 0.0   EBIT   623 700 849 575 1,026 617 0.0 0.0   Pre-tax profit (PTP)   590.7 681.4 845.3 574.5 1,026.7 642.0 0.0 0.0   Net earnings   460.5 531.4 659.1 446.7 800.7 500.8 0.0 0.0   Pre-tax profit without non-rec. items   591 681 845 575 1,027 642 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   33.6 13.6 17.9 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   642 565 1,114 1,161 1,847 2,230 2,058 2,058   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,387 1,061 1,232 1,227 1,881 2,277 2,058 2,058   Net Debt   -114 -87.3 -485 -63.5 -1,429 -2,004 -2,058 -2,058     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,498 1,562 1,670 1,473 1,745 1,328 0.0 0.0   Gross profit growth   1.5% 4.3% 6.9% -11.8% 18.4% -23.9% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   -687.3 -674.9 -633.7 -712.9 -719.0 -710.8 0.0 0.0   Balance sheet total (assets)   1,387 1,061 1,232 1,227 1,881 2,277 2,058 2,058   Balance sheet change%   -6.7% -23.5% 16.1% -0.4% 53.3% 21.1% -9.6% 0.0%   Added value   1,497.6 1,562.0 1,670.1 1,473.1 1,929.7 1,327.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -374 -374 -350 180 -717 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   41.6% 44.8% 50.9% 39.0% 58.8% 46.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   43.4% 57.2% 74.1% 46.8% 66.1% 30.9% 0.0% 0.0%   ROI %   80.3% 115.9% 101.2% 50.4% 68.1% 31.5% 0.0% 0.0%   ROE %   71.3% 88.0% 78.5% 39.3% 53.2% 24.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   46.3% 53.3% 90.4% 94.6% 98.2% 97.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -14.1% -9.8% -46.8% -8.4% -139.3% -325.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   24.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 1.1 7.5 8.8 55.2 48.3 0.0 0.0   Current Ratio   0.2 1.1 7.5 8.8 55.2 48.3 0.0 0.0   Cash and cash equivalent   114.1 87.3 485.1 63.5 1,428.6 2,003.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -579.2 50.4 761.7 452.4 1,846.9 2,229.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0